None listed
Conditions
Interventions
Drug, Procedure/Surgery : Group A: Normal saline injection
Inject 0.2 cc of saline 4mL into the subcutaneous layer and muscle layer of the surgical incision using a 31 gauge needle at 1cm intervals.
Group B: Botulinum toxin
After completely dissolving 50 units of botulinum toxin in 4mL of 0.9% saline, 0.2 cc (2.5U) is injected at intervals of 1cm into the subcutaneous layer and muscle layer (wide neck root) of the surgic
Sponsors
The Catholic University of Korea, St. Vincent's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participant who is scheduled to undergo thyroid or tumor in neck through a cervical skin incision, and who heard the explanation of this clinical trial, voluntarily decided to participate and sign it.
Exclusion criteria
Exclusion criteria: - Children under 19 years old / Seniors over 75 years old - Pregnant or planning to become pregnant within 6 months, lactating women - When it is expected that regular follow-up cannot be performed - No surgery after consent or other surgery (robot surgery or endoscopy) surgery) - Myasthenia gravis or peripheral motor nervous system disease - If had radiation therapy before - If external radiation is planned after surgery - If the scheduled operation is a reoperation in the same area - When a drainage tube is inserted into the skin incision (in case of incision drainage due to deep cervical infection, etc.) - If known to have keloid - If allergic to botulinum toxin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vancouver scar scale (VSS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Global assessment score (GAS) | — |
Countries
Korea, Republic of
Contacts
Public ContactJung-Hae Cho
The Catholic University of Korea, St. Vincent's Hospital
Outcome results
None listed